Hidemasa Kaneko
Direktor/Vorstandsmitglied bei Almex PE, Inc.
Ursprung des Netzwerks ersten Grades von Hidemasa Kaneko
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Almex PE, Inc.
 Almex PE, Inc. Engineering & ConstructionIndustrial Services Almex PE, Inc. provides engineering and maintenance services for surface treatment equipment. It also manufactures and distributes chemical products. The company was founded in June 1966 and is headquartered in Kanuma, Japan.
4
| Holding Company | Engineering & Construction | 4 |
RBG Partners KK
 RBG Partners KK Investment ManagersFinance RBG Partners KK engages in the operation and management of investment business partnership assets. It also deals with the acquisition and holding of securities and offers consulting services for company diagnosis and investment planning. The company was founded on October 2, 2018 and is headquartered in Yokohama, Japan.
2
| Private Company | Investment Managers | 2 |
WITH Corp.
 WITH Corp. Electronic Equipment/InstrumentsElectronic Technology WITH Corp. engages in development, publishing, and distribution of audio books, educational toys, and promotional products. It also engages in the plan, manufacture and module process of electronic components. The company was founded on June 21, 1976 and is headquartered in Tokyo, Japan.
2
| Private Company | Electronic Equipment/Instruments | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Hidemasa Kaneko
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
SMBC Venture Capital KK
 SMBC Venture Capital KK Investment ManagersFinance SMBC Venture Capital KK (SMBC Venture Capital) is a Private Equity firm, a subsidiary of Sumitomo Mitsui Banking Corp., itself a subsidiary of publicly traded company Sumitomo Mitsui Financial Group, Inc. (TK:8316) founded in 2005. The firm is headquartered in Tokyo. | Investment Managers | Private Equity Investor | |
ARTham Therapeutics, Inc.
 ARTham Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Kaken Pharmaceutical Co., Ltd., ARTham Therapeutics, Inc. is a pharmaceutical company based in Yokohama, Japan. The Japanese company's mission is to deliver "medicines that matter" to improve patient health and contribute to enhanced quality of life through the development of innovative disease-modifying medicines. The company was founded by Sham Nikam, Naoto Uemura, and has been led by CEO Hiroshi Nagabukuro since 2018. ARTham Therapeutics was acquired by Kaken Pharmaceutical Co., Ltd. on December 13, 2021 for $111.95 million. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Japan | 3 |
Sektoral
| Finance | 2 |
| Health Technology | 2 |
Operativ
| Director/Board Member | 9 |
| President | 2 |
| Private Equity Investor | 1 |
| Chairman | 1 |
| Chief Operating Officer | 1 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Hidemasa Kaneko
- Unternehmensverbindungen
